Kasra Karamlou MD in Cleveland, Ohio

Home Ohio Cleveland

Kasra Karamlou MD has Hematology/oncology as his primary medical specialty. Their primary office is: 9500 Euclid Ave in Cleveland, Ohio.

They're a part of the: Cleveland Clinic Foundation medical group which has around 5,601 members. You can call their office at 216-442-1270 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended George Washington University School Of Medicine and graduated in 1996 (around 28 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Kasra Karamlou MD Office Phone and Directions

Kasra Karamlou MD
Cleveland Clinic Foundation
9500 Euclid Ave
Cleveland, Ohio 44195
216-442-1270

Patient Ratings
Please rate your experience with Kasra Karamlou MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 216-442-1270

Enter a starting address:

Healthcare Info for Kasra Karamlou MD

Medical School: George Washington University School Of Medicine
Graduation Year: 1996
The Primary Medical Specialty for Kasra Karamlou MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 28
PAC (PECOS ID)#: 7416984273
NPI #: 1548263163
NPI Created On: 05/27/2005
NPI Last Updated Listed as: 04/28/2023
Primary Taxonomy Code: 207RH0003X
License Number:
MD22283
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Health Net of Arizona, Inc.
Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Farsi, English.

Services and Procedures include:

Bone marrow biopsy and aspiration
Urinalysis, manual test
Vaccine for influenza for injection into muscle
Routine ekg using at least 12 leads including interpretation and report
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 45 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788369885

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $1,925

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788369887

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 795033161

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 795033165

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $2,700

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 795033169

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $2,025

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 795033173

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $2,025

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 795033177

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $84

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818581115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $112

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801689805

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $1,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801691901

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Hematology/oncology Professionals in Cleveland

1.
Seth Corey

9500 Euclid Ave
Cleveland, OH
Cleveland Clinic Foundation

2.
Baidehi Maiti

9500 Euclid Ave
Cleveland, OH
Cleveland Clinic Foundation

3.
Melinda Hsu

11100 Euclid Ave
Cleveland, OH
University Hospitals Medical Group Inc

4.
Brian Bolwell MD

9500 Euclid Ave
Cleveland, OH
Cleveland Clinic Foundation

5.
Crawford Strunk MD

9500 Euclid Ave
Cleveland, OH
Cleveland Clinic Foundation

6.
Qian Wang

11100 Euclid Ave
Cleveland, OH
University Hospitals Medical Group Inc

Providers in Cleveland Clinic Foundation

1.Ksenia Aaron

9500 Euclid Ave
Cleveland Oh 44195-0001
Cleveland Clinic Foundation
Otolaryngology

2.Katarina Abadie

9500 Euclid Ave
Cleveland Oh 44195-0001
Cleveland Clinic Foundation
Family Practice

3.Cassandra Abbatemarco

9500 Euclid Ave
Cleveland Oh 44195-0001
Cleveland Clinic Foundation
Nurse Practitioner

4.Mohamed Abdallah

9500 Euclid Ave
Cleveland Oh 44195-0001
Cleveland Clinic Foundation
Gastroenterology

5.Abdelrahman Abdelaziz

9500 Euclid Ave
Cleveland Oh 44195-0001
Cleveland Clinic Foundation
Psychiatry

6.Bahaa Abdelghaffar

9500 Euclid Ave
Cleveland Oh 44195-0001
Cleveland Clinic Foundation
Internal Medicine

View all 5,601 members of Cleveland Clinic Foundation medical group